array:41 [
  "USER" => "www-data"
  "HOME" => "/var/www"
  "SCRIPT_NAME" => "/index.php"
  "REQUEST_URI" => "/news/eli-lillys-stock-rises-after-its-zepbound-weight-loss-drug-achieved-better-results-than-rival-wegovy-in-a-head-to-head-trial"
  "QUERY_STRING" => ""
  "REQUEST_METHOD" => "GET"
  "SERVER_PROTOCOL" => "HTTP/1.1"
  "GATEWAY_INTERFACE" => "CGI/1.1"
  "REDIRECT_URL" => "/news/eli-lillys-stock-rises-after-its-zepbound-weight-loss-drug-achieved-better-results-than-rival-wegovy-in-a-head-to-head-trial"
  "REMOTE_PORT" => "16937"
  "SCRIPT_FILENAME" => "/var/www/dev.stocks.news/public_html/public/index.php"
  "SERVER_ADMIN" => "[no address given]"
  "CONTEXT_DOCUMENT_ROOT" => "/var/www/dev.stocks.news/public_html/public"
  "CONTEXT_PREFIX" => ""
  "REQUEST_SCHEME" => "https"
  "DOCUMENT_ROOT" => "/var/www/dev.stocks.news/public_html/public"
  "REMOTE_ADDR" => "216.73.216.240"
  "SERVER_PORT" => "443"
  "SERVER_ADDR" => "172.31.25.252"
  "SERVER_NAME" => "dev.stocks.news"
  "SERVER_SOFTWARE" => "Apache/2.4.52 (Ubuntu)"
  "SERVER_SIGNATURE" => "<address>Apache/2.4.52 (Ubuntu) Server at dev.stocks.news Port 443</address>\n"
  "PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin:/snap/bin"
  "HTTP_HOST" => "dev.stocks.news"
  "HTTP_ACCEPT_ENCODING" => "gzip, br, zstd, deflate"
  "HTTP_USER_AGENT" => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  "HTTP_ACCEPT" => "*/*"
  "proxy-nokeepalive" => "1"
  "SSL_TLS_SNI" => "dev.stocks.news"
  "HTTPS" => "on"
  "SCRIPT_URI" => "https://dev.stocks.news/news/eli-lillys-stock-rises-after-its-zepbound-weight-loss-drug-achieved-better-results-than-rival-wegovy-in-a-head-to-head-trial"
  "SCRIPT_URL" => "/news/eli-lillys-stock-rises-after-its-zepbound-weight-loss-drug-achieved-better-results-than-rival-wegovy-in-a-head-to-head-trial"
  "REDIRECT_STATUS" => "200"
  "REDIRECT_SSL_TLS_SNI" => "dev.stocks.news"
  "REDIRECT_HTTPS" => "on"
  "REDIRECT_SCRIPT_URI" => "https://dev.stocks.news/news/eli-lillys-stock-rises-after-its-zepbound-weight-loss-drug-achieved-better-results-than-rival-wegovy-in-a-head-to-head-trial"
  "REDIRECT_SCRIPT_URL" => "/news/eli-lillys-stock-rises-after-its-zepbound-weight-loss-drug-achieved-better-results-than-rival-wegovy-in-a-head-to-head-trial"
  "FCGI_ROLE" => "RESPONDER"
  "PHP_SELF" => "/index.php"
  "REQUEST_TIME_FLOAT" => 1778553830.807
  "REQUEST_TIME" => 1778553830
]
Stocks News

Eli Lilly's stock rises after its Zepbound weight-loss drug achieved better results than rival Wegovy in a head-to-head trial

Select an alert type

Setup alert

Exclusive Content

Privacy Preferences
